| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,
Department of Virology, Faculty of Medicine, Imperial College London, St Mary's Campus, Norfolk Place, London W2 1PG, UK
Correspondence
Geoffrey L. Smith
glsmith{at}imperial.ac.uk
Vaccinia virus (VACV) produces two distinct enveloped virions, the intracellular mature virus (IMV) and the extracellular enveloped virus (EEV), but the entry mechanism of neither virion is understood. Here, the binding and entry of IMV particles have been investigated. The cell receptors for IMV are unknown, but it was proposed that IMV can bind to glycosaminoglycans (GAGs) on the cell surface and three IMV surface proteins have been implicated in this. In this study, the effect of soluble GAGs on IMV infectivity was reinvestigated and it was demonstrated that GAGs affected IMV infectivity partially in some cells, but not at all in others. Therefore, binding of IMV to GAGs is cell type-specific and not essential for IMV entry. By using electron microscopy, it is demonstrated that IMV from strains Western Reserve and modified virus Ankara enter cells by fusion with the plasma membrane. After an IMV particle bound to the cell, the IMV membrane fused with the plasma membrane and released the virus core into the cytoplasm. IMV surface antigen became incorporated into the plasma membrane and was not left outside the cell, as claimed in previous studies. Continuity between the IMV membrane and the plasma membrane was confirmed by tilt-series analysis to orientate membranes perpendicularly to the beam of the electron microscope. This analysis shows unequivocally that IMV is surrounded by a single lipid membrane and enters by fusion at the cell surface.
These authors contributed equally to this work.
Present address: Department of Immunology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
This article has been cited by other articles:
|
|
 |
|
  C. N. Fogg, J. L. Americo, P. L. Earl, W. Resch, L. Aldaz-Carroll, R. J. Eisenberg, G. H. Cohen, and B. Moss Disparity between Levels of In Vitro Neutralization of Vaccinia Virus by Antibody to the A27 Protein and Protection of Mice against Intranasal Challenge J. Virol., August 15, 2008; 82(16): 8022 - 8029. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. E. Nelson, T. R. Wagenaar, and B. Moss A Conserved Sequence within the H2 Subunit of the Vaccinia Virus Entry/Fusion Complex Is Important for Interaction with the A28 Subunit and Infectivity J. Virol., July 1, 2008; 82(13): 6244 - 6250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. R. Wagenaar, S. Ojeda, and B. Moss Vaccinia Virus A56/K2 Fusion Regulatory Protein Interacts with the A16 and G9 Subunits of the Entry Fusion Complex J. Virol., June 1, 2008; 82(11): 5153 - 5160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Mercer and A. Helenius Vaccinia Virus Uses Macropinocytosis and Apoptotic Mimicry to Enter Host Cells Science, April 25, 2008; 320(5875): 531 - 535. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. D. Vermeer, J. McHugh, T. Rokhlina, D. W. Vermeer, J. Zabner, and M. J. Welsh Vaccinia Virus Entry, Exit, and Interaction with Differentiated Human Airway Epithelia J. Virol., September 15, 2007; 81(18): 9891 - 9899. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Townsley and B. Moss Two Distinct Low-pH Steps Promote Entry of Vaccinia Virus J. Virol., August 15, 2007; 81(16): 8613 - 8620. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. R. Wagenaar and B. Moss Association of Vaccinia Virus Fusion Regulatory Proteins with the Multicomponent Entry/Fusion Complex J. Virol., June 15, 2007; 81(12): 6286 - 6293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Husain, A. S. Weisberg, and B. Moss Sequence-Independent Targeting of Transmembrane Proteins Synthesized within Vaccinia Virus Factories to Nascent Viral Membranes J. Virol., March 15, 2007; 81(6): 2646 - 2655. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Brown, T. G. Senkevich, and B. Moss Vaccinia Virus F9 Virion Membrane Protein Is Required for Entry but Not Virus Assembly, in Contrast to the Related L1 Protein J. Virol., October 1, 2006; 80(19): 9455 - 9464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ojeda, A. Domi, and B. Moss Vaccinia Virus G9 Protein Is an Essential Component of the Poxvirus Entry-Fusion Complex J. Virol., October 1, 2006; 80(19): 9822 - 9830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Townsley, A. S. Weisberg, T. R. Wagenaar, and B. Moss Vaccinia Virus Entry into Cells via a Low-pH-Dependent Endosomal Pathway. J. Virol., September 1, 2006; 80(18): 8899 - 8908. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Rahbar, T. T. Murooka, A. A. Hinek, C. L. Galligan, A. Sassano, C. Yu, K. Srivastava, L. C. Platanias, and E. N. Fish Vaccinia Virus Activation of CCR5 Invokes Tyrosine Phosphorylation Signaling Events That Support Virus Replication J. Virol., July 15, 2006; 80(14): 7245 - 7259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Law, G. C. Carter, K. L. Roberts, M. Hollinshead, and G. L. Smith From the Cover: Ligand-induced and nonfusogenic dissolution of a viral membrane PNAS, April 11, 2006; 103(15): 5989 - 5994. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ojeda, T. G. Senkevich, and B. Moss Entry of Vaccinia Virus and Cell-Cell Fusion Require a Highly Conserved Cysteine-Rich Membrane Protein Encoded by the A16L Gene J. Virol., January 1, 2006; 80(1): 51 - 61. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. I. Okeke, O. Nilssen, and T. Traavik Modified vaccinia virus Ankara multiplies in rat IEC-6 cells and limited production of mature virions occurs in other mammalian cell lines J. Gen. Virol., January 1, 2006; 87(1): 21 - 27. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
